Blue Bear Ventures - aVenture Asset Manager Research
Location
Berkeley, CA, US
Founded
2017
Blue Bear Ventures (BBV) focuses on deep tech investments, particularly in sustainable economies, applied biology, and emerging technologies. The firm engages with founders working on cutting-edge scientific and technological innovations aimed at addressing pressing global challenges. BBV typically invests in seed and early-stage rounds, with investments ranging from $50,000 to $1.5 million.
Notable portfolio companies include ImpriMed, a precision medicine platform for veterinary oncology, and Unnatural Products, which develops novel therapeutics using AI-driven molecular design. BBV has formed a strategic partnership with BCG through their Transitions First initiative, aiming to foster collaboration between corporates and startups. The firm's investment philosophy centers on supporting groundbreaking discoveries with the potential for significant global impact.
Blue Bear Ventures - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies4
Current Portfolio Count4
Top Investment Stages
Seed3 (75.0%)
Angel1 (25.0%)
Stage Mix
Seed 75%Angel 25%
Concentration shown as share of disclosed investments by stage.